These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9628869)

  • 21. Structural basis of spirolactone recognition by the mineralocorticoid receptor.
    Huyet J; Pinon GM; Fay MR; Fagart J; Rafestin-Oblin ME
    Mol Pharmacol; 2007 Sep; 72(3):563-71. PubMed ID: 17569793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors.
    Baker ME; Funder JW; Kattoula SR
    J Steroid Biochem Mol Biol; 2013 Sep; 137():57-70. PubMed ID: 23907018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A DFT-D investigation of the mechanisms for activation of the wild-type and S810L mutated mineralocorticoid receptor by steroid hormones.
    Riley KE; Hobza P
    J Phys Chem B; 2008 Mar; 112(10):3157-63. PubMed ID: 18284228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of steroid ligands able to inactivate the mineralocorticoid receptor harboring the S810L mutation responsible for a severe form of hypertension.
    Pinon GM; Fagart J; Souque A; Auzou G; Vandewalle A; Rafestin-Oblin ME
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):181-8. PubMed ID: 15134816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor.
    Bledsoe RK; Madauss KP; Holt JA; Apolito CJ; Lambert MH; Pearce KH; Stanley TB; Stewart EL; Trump RP; Willson TM; Williams SP
    J Biol Chem; 2005 Sep; 280(35):31283-93. PubMed ID: 15967794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific hydroxylations determine selective corticosteroid recognition by human glucocorticoid and mineralocorticoid receptors.
    Hellal-Levy C; Couette B; Fagart J; Souque A; Gomez-Sanchez C; Rafestin-Oblin M
    FEBS Lett; 1999 Dec; 464(1-2):9-13. PubMed ID: 10611474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular evolution of the switch for progesterone and spironolactone from mineralocorticoid receptor agonist to antagonist.
    Fuller PJ; Yao YZ; Jin R; He S; Martín-Fernández B; Young MJ; Smith BJ
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18578-18583. PubMed ID: 31439819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor.
    Govindan MV; Warriar N
    J Biol Chem; 1998 Sep; 273(38):24439-47. PubMed ID: 9733735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The conserved residues of the ligand-binding domains of steroid receptors are located in the core of the molecules.
    Maeda M
    J Mol Graph Model; 2001; 19(6):543-51, 601-6. PubMed ID: 11552682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms.
    Hultman ML; Krasnoperova NV; Li S; Du S; Xia C; Dietz JD; Lala DS; Welsch DJ; Hu X
    Mol Endocrinol; 2005 Jun; 19(6):1460-73. PubMed ID: 15761029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligand-induced conformational changes in the mineralocorticoid receptor analyzed by protease mapping.
    Trapp T; Holsboer F
    Biochem Biophys Res Commun; 1995 Oct; 215(1):286-91. PubMed ID: 7575603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homology modelling of the ligand-binding domain of glucocorticoid receptor: binding site interactions with cortisol and corticosterone.
    Dey R; Roychowdhury P; Mukherjee C
    Protein Eng; 2001 Aug; 14(8):565-71. PubMed ID: 11579225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
    Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
    Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.
    Riepe FG; Finkeldei J; de Sanctis L; Einaudi S; Testa A; Karges B; Peter M; Viemann M; Grötzinger J; Sippell WG; Fejes-Toth G; Krone N
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4552-61. PubMed ID: 16954160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct functions of the 90 kDa heat-shock protein (hsp90) in oestrogen and mineralocorticosteroid receptor activity: effects of hsp90 deletion mutants.
    Binart N; Lombès M; Baulieu EE
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):797-804. PubMed ID: 7487934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation.
    Deppe CE; Heering PJ; Viengchareun S; Grabensee B; Farman N; Lombès M
    Endocrinology; 2002 May; 143(5):1932-41. PubMed ID: 11956176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
    Tallec LP; Kirsh O; Lecomte MC; Viengchareun S; Zennaro MC; Dejean A; Lombès M
    Mol Endocrinol; 2003 Dec; 17(12):2529-42. PubMed ID: 14500761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor.
    Rogerson FM; Yao Y; Smith BJ; Fuller PJ
    Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):704-9. PubMed ID: 15554912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel interactions of the mineralocorticoid receptor.
    Fuller PJ
    Mol Cell Endocrinol; 2015 Jun; 408():33-7. PubMed ID: 25662276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural determinants of ligand binding to the mineralocorticoid receptor.
    Huyet J; Pinon GM; Fay MR; Rafestin-Oblin ME; Fagart J
    Mol Cell Endocrinol; 2012 Mar; 350(2):187-95. PubMed ID: 21820032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.